Articles tagged "Graft survival"

2021 American Transplant Congress
Comparison of Kidney Transplantation Outcomes Between Donors After Controlled Circulatory Death and Brain Death Donors in Catalonia, Spain
J. Juega¹, M. Pérez-Sáez², J. Comas³, A. Zapatero⁴, M. Crespo², J. Tort³, R. Lauzurica¹, J. Pascual²
¹Nephrology, Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain, ²Nephrology, Hospital del Mar, Barcelona, Spain, ³Departament de Salut, Organització Catalana de Trasplantaments (OCATT), Barcelona, Spain, ⁴Intensive care unit, Hospital del Mar, Barcelona, Spain
*Purpose: The number of kidney transplants (KT) from controlled cardiac death donors (cDCD) has exponentially increased in Spain during the last years. Results from cDCD…
2021 American Transplant Congress
The Clinical Significance of Preformed C1q-binding Donor-specific HLA Antibodies in Kidney Transplantation
S. Lee¹, C. Yang², B. Chung²
¹Seoul National University Hospital, Seoul, Korea, Republic of, ²Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of
*Purpose: Complement activation is one dominant mechanism which cause allograft injury in kidney transplantation (KT). Anti-HLA donor-specific antibodies (DSA) that bind to HLA molecules on…
2021 American Transplant Congress
Enteric Conversion After Bladder-drained Kidney-pancreas Transplantation
S. Sivan, M. Ortigosa-Goggins, M. Patel, M. Morsi, L. Chen, J. Figueiro, G. Ciancio, G. Burke
Miami Transplant Institute, University of Miami Miller School of Medicine, Jackson Memorial Hospital, Miami, FL
*Purpose: In simultaneous kidney-pancreas transplantation (SPK), bladder (BD) and enteric (ED) are both options for pancreaticoduodenal exocrine drainage. While BD provides good early and long…
2021 American Transplant Congress
Worsening Impact of Acute Kidney Rejection on Long Term Graft Survival from 2000 to 2014
D. Leeser¹, W. Irish¹, K. Ravindra², V. Villani², A. Connor², J. Tuttle¹
¹Surgery, East Carolina University, Greenville, NC, ²Surgery, Duke University, Durham, NC
*Purpose: Acute rejection (AR) has been shown to impact graft survival after kidney transplant (KTx), however there is limited data on its impact on long…
2021 American Transplant Congress
The Efficacy of Delayed Fc-nonbinding Anti-CD3 Antibody Treatment in Sensitized Allogeneic Mouse Heart Transplantation
T. Ota¹, R. Goto¹, R. Kanazawa¹, K. Shibuya¹, Y. Ganchiku¹, N. Kawamura², M. Watanabe², M. Fukai¹, T. Shimamura³, A. Taketomi¹
¹Dept. of Gastroenterological Surgery I, Hokkaido University, Sapporo, Japan, ²Dept. of Transplant Surgery, Hokkaido University, Sapporo, Japan, ³Division of Organ Transplantation, Hokkaido University Hospital, Sapporo, Japan
*Purpose: Delayed treatment with Fc-nonbinding anti-CD3 antibody (ab) permits early graft infiltrating cells to promotes a transplant tolerance. However, graft infiltrating cells immediate after transplantation…
2021 American Transplant Congress
The Implications of Donor-Recipient Size Mismatch in Renal Transplantation
I. D. Kostakis, N. Karydis, T. Kassimatis, N. Kessaris, I. Loukopoulos
Department of Transplantation, Guy’s Hospital, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
*Purpose: Transplanting kidneys small for the recipient’s size results in inferior renal graft function. Body surface area (BSA) is related to kidney size. We used…
2021 American Transplant Congress
Kidney Transplantation Outcomes Over Last Six Decades- A Single-center Experience
A. Dinesh¹, S. Jackson², A. Matas¹
¹University of Minnesota Medical School, Minneapolis, MN, ²Analytics Consulting Services, M Health Fairview, Minneapolis, MN
*Purpose: During the last 6 decades, the science around kidney transplantation has evolved tremendously resulting in significant improvements in kidney allograft and patient survival. There…
2021 American Transplant Congress
Controlled Donation After Circulatory Death Pancreas Transplantation in Spain. Initial Experience
J. Ferrer-Fàbrega¹, R. Muñoz², J. Ruiz³, D. Casanova⁴, F. Sánchez-Bueno⁵, J. Pérez-Daga⁶, C. Fernández-Rivera⁷, M. Gómez⁸, F. Castillo⁹, R. López-Andújar¹⁰, J. Maupoey¹⁰, J. Briceño¹¹, J. Sánchez-Hidalgo¹¹, Á. Arjona¹¹, A. Álvarez¹², A. Alarcó¹³, A. Bravo¹³, R. García¹, R. Rull¹, M. López-Boado¹, P. Ventura-Aguiar¹⁴, F. Diekmann¹⁴, D. Paredes¹⁵, J. García-Valdecasas¹, J. Fuster¹, C. Fondevila¹, B. Domínguez-Gil²
¹Hepatobiliopancreatic Surgery and Transplantation Department, Hospital Clínic Barcelona, Barcelona, Spain, ²Organización Nacional de Trasplantes (ONT), Madrid, Spain, ³Department of Nephrology., University Hospital Marques de Valdecilla. University Cantabria, Santander., Santander, Spain, ⁴Department of Surgery, University Hospital Marques de Valdecilla, University Cantabria, Santander., Santander, Spain, ⁵Department of General, Visceral and Transplantation Surgery., Clinic and University Hospital Virgen de la Arrixaca. IMIB-ARRIXACA. Murcia., Murcia, Spain, ⁶Department of Surgery, Hospital Regional de Málaga. Málaga., Málaga, Spain, ⁷Department of Nephrology., Complexo Hospitalario Universitario de A Coruña. A Coruña, A Coruña, Spain, ⁸Department of Surgery, Complexo Hospitalario Universitario de A Coruña. A Coruña, A Coruña, Spain, ⁹Department of Surgery, University Hospital Marques de Valdecilla. University Cantabria, Santander., Santander, Spain, ¹⁰Hepato-Pancreatico-Biliary Surgery and Transplant Unit, La Fe University Hospital. Valencia, Valencia, Spain, ¹¹Department of Surgery, Hospital Universitario Reina Sofía. Córdoba, Córdoba, Spain, ¹²Department of Nephrology., Hospital Universitario de Canarias. Tenerife., Tenerife, Spain, ¹³Department of Surgery, Hospital Universitario de Canarias. Tenerife., Tenerife, Spain, ¹⁴Renal Transplant Unit, Hospital Clínic Barcelona, Barcelona, Spain, ¹⁵Coordination Department, Hospital Clínic Barcelona, Barcelona, Spain
*Purpose: To report on the Spanish Pancreas Transplantation experience in controlled donation after circulatory death (cDCD) by analyzing the normothermic regional perfusion (NRP) and super-rapid…
2021 American Transplant Congress
Impact of Graft Quality on Patient Survival in Sick Patients
G. Handing¹, S. Keeling¹, C. Christmann¹, N. Galvan², C. O’Mahony², J. Goss², R. Cotton², A. Rana²
¹School of Medicine, Baylor College of Medicine, Houston, TX, ²Michael E DeBakey Department of Surgery, Division of Abdominal Transplant, Houston, TX
*Purpose: It is widely accepted in the literature that patients who have a Model for End Stage Liver Disease (MELD) Score greater than 30 incur…
2021 American Transplant Congress
Autoimmune Responses to DNA Topoisomerase I Exacerbate Renal Allograft Injury
V. Gorbacheva, R. Fan, S. Miyairi, W. Baldwin, R. Fairchild, A. Valujskikh
Inflammation and Immunity, Cleveland Clinic, Cleveland, OH
*Purpose: Multiple clinical and pre-clinical studies describe correlations between pre-existing or de novo autoimmune responses and poor transplant outcome. We have previously reported that following…